172 related articles for article (PubMed ID: 20564139)
1. Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse.
Lai HC; Lin YW; Huang RL; Chung MT; Wang HC; Liao YP; Su PH; Liu YL; Yu MH
Cancer; 2010 Sep; 116(18):4266-74. PubMed ID: 20564139
[TBL] [Abstract][Full Text] [Related]
2. Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm.
Chang CC; Huang RL; Liao YP; Su PH; Hsu YW; Wang HC; Tien CY; Yu MH; Lin YW; Lai HC
BMC Cancer; 2015 May; 15():418. PubMed ID: 25985991
[TBL] [Abstract][Full Text] [Related]
3. Real-time colorimetric detection of DNA methylation of the
Huang J; Liou YL; Kang YN; Tan ZR; Peng MJ; Zhou HH
Int J Nanomedicine; 2016; 11():5335-5347. PubMed ID: 27789946
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
[TBL] [Abstract][Full Text] [Related]
5. Assessing methylation status of PAX1 in cervical scrapings, as a novel diagnostic and predictive biomarker, was closely related to screen cervical cancer.
Xu J; Xu L; Yang B; Wang L; Lin X; Tu H
Int J Clin Exp Pathol; 2015; 8(2):1674-81. PubMed ID: 25973053
[TBL] [Abstract][Full Text] [Related]
6. PAX1 methylation as a potential biomarker for cervical cancer screening.
Kan YY; Liou YL; Wang HJ; Chen CY; Sung LC; Chang CF; Liao CI
Int J Gynecol Cancer; 2014 Jun; 24(5):928-34. PubMed ID: 24844223
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel DNA methylation markers in cervical cancer.
Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
[TBL] [Abstract][Full Text] [Related]
8. PAX1/SOX1 DNA methylation and cervical neoplasia detection: a Taiwanese Gynecologic Oncology Group (TGOG) study.
Lai HC; Ou YC; Chen TC; Huang HJ; Cheng YM; Chen CH; Chu TY; Hsu ST; Liu CB; Hung YC; Wen KC; Yu MH; Wang KL
Cancer Med; 2014 Aug; 3(4):1062-74. PubMed ID: 24799352
[TBL] [Abstract][Full Text] [Related]
9. [A multicenter study on the accuracy of PAX1/JAM3 dual genes methylation testing for screening cervical cancer].
Shang X; Kong LH; Xiao XP; Wan R; Wang J; Wu HW; Chen XY; Shou HF; Fei J; Zhou JW; Lang JH; Li L
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1852-1859. PubMed ID: 38782754
[No Abstract] [Full Text] [Related]
10. Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy.
Lim EH; Ng SL; Li JL; Chang AR; Ng J; Ilancheran A; Low J; Quek SC; Tay EH
Gynecol Oncol; 2010 Nov; 119(2):225-31. PubMed ID: 20708786
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation analysis of host genes in cervical intraepithelial neoplasia and cervical cancers on histological cervical specimens.
Shi L; Yang X; He L; Zheng C; Ren Z; Warsame JA; Suye S; Yan L; Cai H; Xiao X; Fu C
BMC Cancer; 2023 Feb; 23(1):168. PubMed ID: 36803573
[TBL] [Abstract][Full Text] [Related]
12. Quantitative DNA methylation analysis of paired box gene 1 and LIM homeobox transcription factor 1 α genes in cervical cancer.
Xu L; Xu J; Hu Z; Yang B; Wang L; Lin X; Xia Z; Zhang Z; Zhu Y
Oncol Lett; 2018 Apr; 15(4):4477-4484. PubMed ID: 29541217
[TBL] [Abstract][Full Text] [Related]
13. DAPK1, MGMT and RARB promoter methylation as biomarkers for high-grade cervical lesions.
Sun Y; Li S; Shen K; Ye S; Cao D; Yang J
Int J Clin Exp Pathol; 2015; 8(11):14939-45. PubMed ID: 26823825
[TBL] [Abstract][Full Text] [Related]
14. Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays.
Dippmann C; Schmitz M; Wunsch K; Schütze S; Beer K; Greinke C; Ikenberg H; Hoyer H; Runnebaum IB; Hansel A; Dürst M
Clin Epigenetics; 2020 Nov; 12(1):171. PubMed ID: 33176878
[TBL] [Abstract][Full Text] [Related]
15. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
[TBL] [Abstract][Full Text] [Related]
16. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
[TBL] [Abstract][Full Text] [Related]
17. High methylation rate of LMX1A, NKX6-1, PAX1, PTPRR, SOX1, and ZNF582 genes in cervical adenocarcinoma.
Chang CC; Huang RL; Wang HC; Liao YP; Yu MH; Lai HC
Int J Gynecol Cancer; 2014 Feb; 24(2):201-9. PubMed ID: 24407576
[TBL] [Abstract][Full Text] [Related]
18. Genotype-specific methylation of HPV in cervical intraepithelial neoplasia.
Hsu YW; Huang RL; Su PH; Chen YC; Wang HC; Liao CC; Lai HC
J Gynecol Oncol; 2017 Jul; 28(4):e56. PubMed ID: 28541643
[TBL] [Abstract][Full Text] [Related]
19. PAX1 methylation as an auxiliary biomarker for cervical cancer screening: a meta-analysis.
Nikolaidis C; Nena E; Panagopoulou M; Balgkouranidou I; Karaglani M; Chatzaki E; Agorastos T; Constantinidis TC
Cancer Epidemiol; 2015 Oct; 39(5):682-6. PubMed ID: 26234429
[TBL] [Abstract][Full Text] [Related]
20. Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3.
Boers A; Wang R; van Leeuwen RW; Klip HG; de Bock GH; Hollema H; van Criekinge W; de Meyer T; Denil S; van der Zee AGJ; Schuuring E; Wisman GBA
Clin Epigenetics; 2016; 8():29. PubMed ID: 26962367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]